Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Aronson

Showing results (361-370 of 634) with videos related to

Pageof 64
Sort By:
Clinical Toxicology (Philadelphia, Pa.)|July 7, 2017
The toxicological significance of post-mortem drug concentrations in bileRobin E Ferner, Jeffrey K Aronson
British Medical Journal (Clinical Research Ed.)|March 30, 1985
Dietary salt and hypertension: treatment and preventionN A Boon, J K Aronson
British Journal of Clinical Pharmacology|August 17, 2022
Medicines legislation and regulation in the United Kingdom 1500-2020Robin E Ferner, Jeffrey K Aronson
Archives of Dermatology|January 21, 2003
Of mice and men: the road to understanding the complex nature of adipose tissue and lipoatrophyIris K Aronson, Virginia C Fiedler
Drug Safety|November 7, 2019
Medical Devices: Classification and Analysis of Faults Leading to HarmsRobin E Ferner, Jeffrey K Aronson
BMJ (Clinical Research Ed.)|December 17, 2013
Laughter and MIRTH (Methodical Investigation of Risibility, Therapeutic and Harmful): narrative synthesisR E Ferner, J K Aronson
British Journal of Clinical Pharmacology|July 16, 2015
Cato Guldberg and Peter Waage, the history of the Law of Mass Action, and its relevance to clinical pharmacologyRobin E Ferner, Jeffrey K Aronson
Aging|December 12, 1983
Coping with Alzheimer's disease through support groupsM K Aronson, E S Yatzkan
BMJ (Clinical Research Ed.)|June 22, 2001
Adverse events in British hospitals. Retrospective case record analysis has been supersededR E Ferner, J K Aronson
Lancet (London, England)|November 10, 2000
Adverse drug reactions: definitions, diagnosis, and managementI R Edwards, J K Aronson
Pageof 64

Showing results (361-370 of 634) with videos related to

Sort By:
Pageof 64
Clinical Toxicology (Philadelphia, Pa.)|July 7, 2017
The toxicological significance of post-mortem drug concentrations in bileRobin E Ferner, Jeffrey K Aronson
British Medical Journal (Clinical Research Ed.)|March 30, 1985
Dietary salt and hypertension: treatment and preventionN A Boon, J K Aronson
British Journal of Clinical Pharmacology|August 17, 2022
Medicines legislation and regulation in the United Kingdom 1500-2020Robin E Ferner, Jeffrey K Aronson
Archives of Dermatology|January 21, 2003
Of mice and men: the road to understanding the complex nature of adipose tissue and lipoatrophyIris K Aronson, Virginia C Fiedler
Drug Safety|November 7, 2019
Medical Devices: Classification and Analysis of Faults Leading to HarmsRobin E Ferner, Jeffrey K Aronson
BMJ (Clinical Research Ed.)|December 17, 2013
Laughter and MIRTH (Methodical Investigation of Risibility, Therapeutic and Harmful): narrative synthesisR E Ferner, J K Aronson
British Journal of Clinical Pharmacology|July 16, 2015
Cato Guldberg and Peter Waage, the history of the Law of Mass Action, and its relevance to clinical pharmacologyRobin E Ferner, Jeffrey K Aronson
Aging|December 12, 1983
Coping with Alzheimer's disease through support groupsM K Aronson, E S Yatzkan
BMJ (Clinical Research Ed.)|June 22, 2001
Adverse events in British hospitals. Retrospective case record analysis has been supersededR E Ferner, J K Aronson
Lancet (London, England)|November 10, 2000
Adverse drug reactions: definitions, diagnosis, and managementI R Edwards, J K Aronson
Pageof 64